GSL: General Sales List
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00014/0497.
Boots Ibuprofen 200 mg Tablets (16 tablets) (GSL)
Information for the user
Boots Ibuprofen 200mg Tablets
Read all of this leaflet carefully because it contains important information for you.
This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it.
What this medicine is for
This medicine contains Ibuprofen which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which act to relieve pain and reduce swelling. It can be used to relieve headaches, rheumatic and muscular pain, backache, migraine, period pain, dental pain and neuralgia. It can also be used to reduce fever and relieve the symptoms of colds and flu.
Before you take this medicine
This medicine can be taken by adults and children aged 12 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.
Do not take if you:
Other important information
Risk of heart attack or stroke:
Anti-inflammatory/pain-killer medicines like ibuprofen may be associated with a small increased risk of heart attack or stroke, particularly when used at high doses. Do not exceed the recommended dose or duration of treatment.
Take special care with Ibuprofen 200mg Tablets.
Skin reactions: Serious skin reactions have been reported in association with ibuprofen treatment. You should stop taking this medicine and seek medical attention immediately, if you develop any skin rash, lesions of the mucous membranes, blisters or other signs of allergy since this can be the first signs of a very serious skin reaction. See "Possible Side Effects".
Talk to your pharmacist or doctor:
Ibuprofen may hide signs of infections such as fever and pain. It is therefore possible that Ibuprofen 200mg tablets may delay appropriate treatment of infection, which may lead to an increased risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If you take this medicine while you have an infection and your symptoms of the infection persist or worsen, consult a doctor without delay.
Woman of childbearing age: If you take this medicine, it may reduce your ability to become pregnant. This effect will be reversed when you stop the medicine.
If you take other medicines
Before you take these tablets, make sure that you tell your doctor or pharmacist about ANY other medicines you might be using at the same time. Ibuprofen may affect or be affected by some other medicines. For example:
How to take this medicine
Check the foil is not broken before use. If it is, do not take that tablet.
Adults and children of 12 years and over:
Take one or two tablets every 4 hours, if you need to.
Don't take more than 6 tablets in 24 hours.
Take the lowest amount for the shortest possible time to relieve your symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section Infections).
Swallow each tablet with water. Do not give to children under 12 years. Do not take more than the amount recommended above.
In adults: If your symptoms worsen or do not go away within 10 days, talk to your doctor.
In children and adolescents (aged 12-18 years old): If this medicinal product is required for more than 3 days, or if symptoms worsen, talk to your doctor.
If you take more tablets than you should:
If you have taken more tablets than you should, or if children have taken the medicine by accident always contact a doctor or nearest hospital to get an opinion on the risk and advice on action to be taken.
The symptoms can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.
Possible side effects
Most people will not have problems, but some may get some. If you are elderly you may be more likely to have some of these side effects.
If you get any of these serious side effects, stop taking the tablets. See a doctor at once:
If you get any of the following side effects see your pharmacist or doctor:
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store this medicine
Store below 25°C.
Store in the original package.
Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard.
Use by the date on the end flap of the carton.
What is in this medicine
Each tablets contains Ibuprofen 200 mg, which is the active ingredient.
As well as the active ingredient, the tablets also contain microcrystalline cellulose, lactose, hypromellose, croscarmellose sodium, sodium laurilsulfate, magnesium stearate, french chalk, colloidal silicon dioxide, titanium dioxide (E171).
The pack contains 16 white capsule shaped tablets.
Who makes this medicine
Manufactured for the Marketing Authorisation holder
Manufacturer responsible for batch release:
Leaflet prepared November 2020
If you would like any further information about this medicine, please contact
Artwork reference; WBAG436069